TVGN
Tevogen Inc.Company Information
- Company Name
- Tevogen Inc.
- CIK
- CIK0001860871
- Category
- <br>Emerging growth company
- Ticker: Exchange
- TVGN: Nasdaq, TVGNW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- TVGN
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-06-12
- Last sale
- 2026-03-13
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 1,438,707
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 108,020
- Shares outstanding
- 3,829,365
- Ownership
- 2.82%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 6.84%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 4 | 2 | 2 | 2 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Assets Held In Trust Noncurrent | - | - | - | - | - | - | - | - | - | - | 17 | 26 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Deferred Costs | 0 | 0 | 0 | 0 | - | - | - | - | - | - | 3 | - | ||||||
| Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | - | 1 | 1 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | - | ||||||
| Assets | 5 | 5 | 4 | 4 | 4 | 4 | 3 | 4 | 3 | 3 | 6 | 26 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Other Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Accounts Payable Current | 3 | 4 | 3 | 3 | 4 | 5 | 5 | 6 | 7 | 5 | 3 | - | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 6 | 7 | 7 | 7 | 8 | 9 | 9 | 10 | 11 | 9 | 85 | 2 | ||||||
| Convertible Notes Payable Current | - | - | - | - | - | - | - | - | - | - | 81 | 1 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | - | - | - | 17 | 26 | ||||||
| Notes Payable Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | - | - | ||||||
| Lines Of Credit Current | - | - | - | - | - | - | - | 1 | - | - | - | - | ||||||
| Convertible Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | 14 | - | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | - | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Derivative Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 14 | 15 | 13 | 12 | 14 | 12 | 10 | 10 | 11 | 9 | 100 | 17 | ||||||
| Preferred Stock Value | - | - | - | - | - | - | - | - | 3 | - | - | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -9 | -10 | -8 | -8 | -9 | -8 | -7 | -6 | -8 | -6 | -94 | -91 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Additional Paid In Capital | 133 | 126 | 123 | 118 | 111 | 107 | 98 | 91 | 88 | 76 | 5 | - | ||||||
| Retained Earnings Accumulated Deficit | -151 | -145 | -140 | -135 | -129 | -124 | -113 | -104 | -98 | -88 | -100 | -16 | ||||||
| Liabilities And Stockholders Equity | 5 | 5 | 4 | 4 | 4 | 4 | 3 | 4 | 3 | 3 | 6 | 26 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | - | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Common Stock Shares Authorized | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | - | ||||||
| Common Stock Shares Issued | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 2 | - | ||||||
| Shares Outstanding | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 2 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTevogen Inc. (TVGN) — SEC Financial Statements & Analysis
Tevogen Inc. (TVGN) is a biological products, (no diagnostic substances) company, incorporated in DE. Tevogen Inc. trades on Nasdaq as: TVGN, TVGNW. Tevogen Inc. (TVGN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Tevogen Inc. carries a market cap of $21.67M, a P/E ratio of -1.01x, a P/B ratio of -2.44x, an enterprise value of $22.24M, and an EV/EBITDA multiple of -1.05x. On profitability, it posts a Return on Equity (ROE) of 233.77% and a Return on Assets (ROA) of -477.40%. Per share, it reports EPS of $-5.61, diluted EPS of $-5.61, free cash flow per share of $-3.02, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -37.15% year-over-year and EPS growth of -45.95% year-over-year. On the balance sheet, it maintains a current ratio of 0.33x, a quick ratio of 0.20x, working capital of $-4.14M, a debt-to-equity ratio of -1.53x, a debt ratio of 2.88, an interest coverage ratio of -70.74x, free cash flow of $-11.57M (TTM), and net debt of $568.85K. Figures sourced from SEC EDGAR.
- Market Cap
- $21.67M
- P/E TTM
- -1.01x
- EPS TTM
- $-5.61
- P/B TTM
- -2.44x
- ROE TTM
- 233.77%
- ROA TTM
- -477.40%
- Debt To Equity
- -1.53x
- Free Cash Flow TTM
- $-11.57M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Tevogen Inc. in?
Tevogen Inc. (TVGN) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does TVGN trade on?
Tevogen Inc. (TVGN) trades on the Nasdaq.
Where is Tevogen Inc. incorporated?
Tevogen Inc. is incorporated in DE.
When was Tevogen Inc. (TVGN)'s most recent SEC filing?
Tevogen Inc. (TVGN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is TVGN's market cap?
Tevogen Inc. (TVGN) has a market capitalization of $21.67M as of 2026-06-30.
What is TVGN's EPS (earnings per share)?
Tevogen Inc. (TVGN)'s trailing twelve month EPS is $-5.61 as of 2026-06-30.
What is TVGN's ROE (return on equity)?
Tevogen Inc. (TVGN)'s trailing twelve month Return on Equity (ROE) is 233.77% as of 2026-06-30.
What is TVGN's ROA (return on assets)?
Tevogen Inc. (TVGN)'s trailing twelve month Return on Assets (ROA) is -477.40% as of 2026-06-30.
What is TVGN's EV/EBITDA?
Tevogen Inc. (TVGN)'s trailing twelve month EV/EBITDA is -1.05x as of 2026-06-30.